AKT-4669

Mrs. Evans is a 54-year-old patient with type 2 diabetes. She was unable to tolerate metformin due to nausea. She has been doing some of her own research into other options and suggests an SGLT-2 inhibitor, empagliflozin, because she has read it might help her lose weight and improve her blood pressure, as well as improve her blood sugar.

What is the mechanism of action of empagliflozin?